Filing Details
- Accession Number:
- 0001214659-13-003594
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-26 17:24:02
- Reporting Period:
- 2013-06-24
- Filing Date:
- 2013-06-26
- Accepted Time:
- 2013-06-26 17:24:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1316175 | Anthera Pharmaceuticals Inc | ANTH | Pharmaceutical Preparations (2834) | 201852016 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1484500 | E. David Thompson | C/O Anthera Pharmaceuticals, Inc., 25801 Industrial Boulevard, Suite B Hayward CA 94545 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-24 | 100,000 | $0.53 | 128,201 | No | 4 | P | Indirect | By David E. Thompson Revocable Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By David E. Thompson Revocable Trust |
Billionaire Hedge Funds
